1. Home
  2. GKOS vs HRL Comparison

GKOS vs HRL Comparison

Compare GKOS & HRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$180.54

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

HOLD

Current Price

$20.55

Market Cap

11.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
HRL
Founded
1998
1891
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Meat/Poultry/Fish
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
11.2B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
GKOS
HRL
Price
$180.54
$20.55
Analyst Decision
Strong Buy
Hold
Analyst Count
13
10
Target Price
★ $199.31
$25.31
AVG Volume (30 Days)
979.8K
★ 4.7M
Earning Date
10-28-2026
12-03-2026
Dividend Yield
N/A
★ 5.68%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.72
Revenue
$507,442,000.00
★ $12,106,160,000.00
Revenue This Year
$36.30
$0.18
Revenue Next Year
$23.25
$1.84
P/E Ratio
★ N/A
$28.59
Revenue Growth
★ 32.33
1.55
52 Week Low
$80.91
$18.96
52 Week High
$191.62
$26.60

Technical Indicators

Market Signals
Indicator
GKOS
HRL
Relative Strength Index (RSI) 65.62 50.38
Support Level $175.04 $20.38
Resistance Level $184.68 $22.03
Average True Range (ATR) 6.45 0.39
MACD 1.90 0.18
Stochastic Oscillator 80.18 67.36

Price Performance

Historical Comparison
GKOS
HRL

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (less than 6%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

Share on Social Networks: